IBDEI0E0 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14003,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,14004,0)
 ;;=L40.0^^61^729^253
 ;;^UTILITY(U,$J,358.3,14004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14004,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,14004,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,14004,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,14005,0)
 ;;=L40.1^^61^729^256
 ;;^UTILITY(U,$J,358.3,14005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14005,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,14005,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,14005,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,14006,0)
 ;;=L40.2^^61^729^11
 ;;^UTILITY(U,$J,358.3,14006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14006,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,14006,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,14006,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,14007,0)
 ;;=L40.3^^61^729^255
 ;;^UTILITY(U,$J,358.3,14007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14007,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,14007,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,14007,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,14008,0)
 ;;=L40.4^^61^729^157
 ;;^UTILITY(U,$J,358.3,14008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14008,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,14008,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,14008,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,14009,0)
 ;;=L40.8^^61^729^252
 ;;^UTILITY(U,$J,358.3,14009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14009,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,14009,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,14009,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,14010,0)
 ;;=L40.9^^61^729^254
 ;;^UTILITY(U,$J,358.3,14010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14010,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,14010,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,14010,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,14011,0)
 ;;=L50.9^^61^729^286
 ;;^UTILITY(U,$J,358.3,14011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14011,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,14011,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,14011,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,14012,0)
 ;;=L53.8^^61^729^147
 ;;^UTILITY(U,$J,358.3,14012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14012,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,14012,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,14012,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,14013,0)
 ;;=L53.9^^61^729^146
 ;;^UTILITY(U,$J,358.3,14013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14013,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,14013,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,14013,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,14014,0)
 ;;=L54.^^61^729^145
 ;;^UTILITY(U,$J,358.3,14014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14014,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,14014,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,14014,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,14015,0)
 ;;=L56.0^^61^729^139
 ;;^UTILITY(U,$J,358.3,14015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14015,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,14015,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,14015,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,14016,0)
 ;;=L56.1^^61^729^138
 ;;^UTILITY(U,$J,358.3,14016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14016,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,14016,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,14016,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,14017,0)
 ;;=L56.2^^61^729^236
 ;;^UTILITY(U,$J,358.3,14017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14017,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,14017,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,14017,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,14018,0)
 ;;=L56.3^^61^729^268
 ;;^UTILITY(U,$J,358.3,14018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14018,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,14018,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,14018,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,14019,0)
 ;;=L57.0^^61^729^12
 ;;^UTILITY(U,$J,358.3,14019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14019,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,14019,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,14019,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,14020,0)
 ;;=L60.0^^61^729^161
 ;;^UTILITY(U,$J,358.3,14020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14020,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,14020,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,14020,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,14021,0)
 ;;=L60.1^^61^729^234
 ;;^UTILITY(U,$J,358.3,14021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14021,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,14021,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,14021,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,14022,0)
 ;;=L60.2^^61^729^233
 ;;^UTILITY(U,$J,358.3,14022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14022,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,14022,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,14022,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,14023,0)
 ;;=L60.3^^61^729^170
 ;;^UTILITY(U,$J,358.3,14023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14023,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,14023,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,14023,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,14024,0)
 ;;=L60.4^^61^729^88
 ;;^UTILITY(U,$J,358.3,14024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14024,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,14024,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,14024,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,14025,0)
 ;;=L60.5^^61^729^290
 ;;^UTILITY(U,$J,358.3,14025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14025,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,14025,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,14025,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,14026,0)
 ;;=L60.8^^61^729^168
 ;;^UTILITY(U,$J,358.3,14026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14026,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,14026,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,14026,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,14027,0)
 ;;=L62.^^61^729^169
 ;;^UTILITY(U,$J,358.3,14027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14027,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,14027,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,14027,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,14028,0)
 ;;=L64.9^^61^729^33
 ;;^UTILITY(U,$J,358.3,14028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14028,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,14028,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,14028,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,14029,0)
 ;;=L65.9^^61^729^231
 ;;^UTILITY(U,$J,358.3,14029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14029,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,14029,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,14029,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,14030,0)
 ;;=L70.0^^61^729^6
 ;;^UTILITY(U,$J,358.3,14030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14030,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,14030,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,14030,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,14031,0)
 ;;=L70.1^^61^729^1
 ;;^UTILITY(U,$J,358.3,14031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14031,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,14031,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,14031,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,14032,0)
 ;;=L70.3^^61^729^5
 ;;^UTILITY(U,$J,358.3,14032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14032,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,14032,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,14032,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,14033,0)
 ;;=L70.5^^61^729^2
 ;;^UTILITY(U,$J,358.3,14033,1,0)
 ;;=^358.31IA^4^2
